Oasmia får ny ordförande

Karo Pharmas ordförande Anders Lönner föreslås även leda Oasmias styrelse i samband med en ny affär mellan bolagen.

Rustar inför exit

Synthetic MR får en ny styrelsetopp lagom till avknoppningen från Accelerator.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Framtidens Life Science snackade trender och utmaningar

Femte upplagan av Lyckad Läkemedelsutveckling gick av stapeln på Grand Hotel i Stockholm den 30 maj. Här hittar du mingelbilder från eventet.

How to get the most out of the fair

Pfizer buys Swiss vaccines

Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Life science management for hire

Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

High hopes for future partnering - the solution for struggling fairs

Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Tillväxtverkets styrelse tillsatt

En framträdande branschprofil från Göteborg ingår.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Agendan: Innovation och skatter

Årets life science-bidrag i Almedalen fokuserar på innovationsstrategier och skattereformer.

Nyfiken rektor

- Det är viljan att förstå hur saker fungerar och hänger ihop som är min drivkraft, säger den nyblivna rektorn.

Självlärd entreprenör

Kommersialisering. Det var många som tyckte att Sarah Fredriksson var naiv när hon som nybakad doktor bestämde sig för att starta ett nanoteknikföretag. Hon kun...